Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000182762 | SCV000235147 | likely pathogenic | not provided | 2012-07-31 | criteria provided, single submitter | clinical testing | p.Pro2462Leu (CCA>CTA): c.7385 C>T in exon 49 of the RYR2 gene (NM_001035.2). The Pro2462Leu variant in the RYR2 gene has not been reported as a disease-causing mutation or as a benign polymorphism to our knowledge. Pro2462Leu results in a non-conservative amino acid substitution of one non-polar residue for another at a position that is conserved across species. In silico analysis predicts Pro2462Leu is probably damaging to the protein structure/function. Mutations in nearby residues (Arg2474Ser, Val2475Phe) have been reported in association with CPVT, further supporting the functional importance of this region of the protein. Furthermore, the NHLBI ESP Exome Variant Server reports Pro2462Leu was not observed in approximately 6,000 samples from individuals of European and African American backgrounds, indicating it is not a common benign variant in these populations. In summary, while Pro2462Leu is a good candidate for a disease-causing mutation, with the clinical and molecular information available at this time we cannot unequivocally determine the clinical significance of this variant. The variant is found in CPVT panel(s). |